Add like
Add dislike
Add to saved papers

Transformation pathway and degradation mechanism of methylene blue through β-FeOOH@GO catalyzed photo-Fenton-like system.

Chemosphere 2018 November 17
To enhance the catalytic and separation properties of akaganéite nanoparticles, rice spike-like akaganéite impregnated graphene oxide (β-FeOOH@GO) nanocomposite was fabricated through facile hydrolysis. The apparent first-order decolorization rate of methylene blue (MB) in β-FeOOH@GO catalyzed photo Fenton-like system was 0.6322 min-1 about 3 folds that of prinstine β-FeOOH nanoparticles. The degradation intermediates of MB adsorbed on the solid surface of β-FeOOH@GO were comprehensively identified with time of flight-secondary ion mass spectroscopy (TOF-SIMS) for the first time. Newly identified sulfoxide intermediates, sulphone intermediates and desulfurization intermediates and N-demethylaton or dedimethamine intermediates were reported for the first time. The proposed degradation pathway of MB predominantly proceeded with the rupture of phenothiazine rings oxided with OH, and singlet oxygen (1 O2 ) radicals, which fully extending the reaction pathways proposed in previous work in literature. The enhanced catalytic activity of β-FeOOH@GO was ascribed to the formation of heterojunctions confirmed by the presence of FeOC chemical bonds through X-ray photoelectron spectroscopy (XPS). The complete elimination of MB and its acute toxicity to Luminous bacteria showed that β-FeOOH@GO would be served as a highly efficient Fenton-like catalyst for treatment of high concentration refractory organic contaminant.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app